5-Mar-2026
Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences
Globe Newswire (Wed, 25-Feb 4:05 PM ET)
Globe Newswire (Mon, 2-Feb 4:05 PM ET)
Globe Newswire (Wed, 7-Jan 4:05 PM ET)
Globe Newswire (Thu, 11-Dec 4:05 PM ET)
Terns Announces Pricing of Upsized $650 Million Public Offering
Globe Newswire (Tue, 9-Dec 11:30 PM ET)
Terns Launches $400 Million Public Offering to Accelerate TERN-701 Oncology Program
Market Chameleon (Tue, 9-Dec 2:31 AM ET)
Terns Announces Proposed Public Offering
Globe Newswire (Tue, 9-Dec 6:12 AM ET)
Globe Newswire (Mon, 8-Dec 2:45 PM ET)
Terns Pharmaceuticals Highlights Innovative Cancer Therapy at Jefferies Global Healthcare Conference
Market Chameleon (Mon, 17-Nov 4:27 AM ET)
Market Chameleon (Tue, 4-Nov 5:34 AM ET)
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
Terns Pharmaceuticals trades on the NASDAQ stock market under the symbol TERN.
As of March 5, 2026, TERN stock price declined to $42.00 with 1,368,025 million shares trading.
TERN has a beta of 1.37, meaning it tends to be more sensitive to market movements. TERN has a correlation of 0.04 to the broad based SPY ETF.
TERN has a market cap of $4.57 billion. This is considered a Mid Cap stock.
In the last 3 years, TERN traded as high as $48.26 and as low as $1.87.
The top ETF exchange traded funds that TERN belongs to (by Net Assets): VTI, IWM, VXF, IWN, IBB.
TERN has outperformed the market in the last year with a price return of +1057.0% while the SPY ETF gained +18.1%. TERN has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +43.1% and +6.5%, respectively, while the SPY returned -0.3% and -0.5%, respectively.
TERN support price is $40.87 and resistance is $44.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TERN shares will trade within this expected range on the day.
